Skip to main content

Find Clinical Trials

Home
Conditions
Atypical Burkitt/Burkitt-Like Lymphoma

Clinical trial condition

Atypical Burkitt/Burkitt-Like Lymphoma

Explore clinical trials studying Atypical Burkitt/Burkitt-Like Lymphoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Atypical Burkitt/Burkitt-Like Lymphoma trial results

Completed

Dose Adjusted EPOCH Regimen in Combination With Ofatumumab or Rituximab in Treating Patients With Newly Diagnosed or Relapsed or Refractory Burkitt Lymphoma or Relapsed or Refractory Acute Lymphoblastic Leukemia

NCT02199184

Conditions: AIDS-Related Burkitt Lymphoma, Atypical Burkitt/Burkitt-Like Lymphoma, Burkitt Lymphoma, +26 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details